Greengro Technologies Inc
Change company Symbol lookup
Select an option...
GRNH Greengro Technologies Inc
CLX Clorox Co
COP ConocoPhillips
FBP First Bancorp
PTCT PTC Therapeutics Inc
ROKU Roku Inc
WORK Slack Technologies Inc
ARKW ARK Next Generation Internet ETF
SPOT Spotify Technology SA
GBTC Grayscale Bitcoin Trust (BTC)
Go

Company profile

GreenGro Technologies, Inc. (GreenGro) provides green technologies focusing on indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. The Company provides manufacturing and sale of vertical cultivation systems and facilities design. Its operating divisions include GRNH, Vertical Hydrogarden, Inc. (VHI) and BP Gardens. GRNH provides design and consulting services to all agricultural divisions, including legalized Cannabis operations. It provides knowledge on designs and systems to maximize production for every crop cycle. VHI is a supplier of green agriculture products, including hydroponics, advanced nutrients, and vertical cultivation technology systems design and sales. VHI also offers leasing and finance solutions, operational and maintenance consulting, and planning services. BP Gardens uses methods to protect crops from detrimental environmental elements while generating market ready leafy green produce year-round in any climate.

Closing Price
$0.0156
Day's Change
-0.0006 (-3.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0195
Day's Low
0.0145
Volume
(Heavy Day)
Volume:
17,904,867

10-day average volume:
14,848,964
17,904,867

Quest Diagnostics To Speak At The Credit Suisse 29th Annual Virtual Healthcare Conference

1:58 pm ET November 3, 2020 (PR Newswire) Print

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 29th Annual Virtual Healthcare Conference. Steve Rusckowski, Chairman, President & CEO will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence, and the company's current perspective on the impact of the COVID-19 pandemic. The presentation is scheduled for Tuesday, November 10, 2020 at 11:45 a.m. Eastern Time.

https://mma.prnewswire.com/media/200883/quest_diagnostics_incorporated_logo_logo.jpg

The presentation will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 48 hours after the conclusion of the live event and will remain available until December 10, 2020.

About Quest DiagnosticsQuest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

About COVID-19 testing at Quest DiagnosticsQuest Diagnostics isat the forefront of the response to the COVID-19 pandemic, working to broaden access to laboratory insights to help us all lead healthier lives. We provide both moleculardiagnostic and antibodyserologytests toaid inthe diagnosis of COVID-19 and immune response. OurCOVID-19 test servicesare based onteststhat have received FDA emergency use authorizationand which alsomeet our high standards for quality.We are providing these test services under the Public Readiness and Emergency Preparedness Act. We providedata onCOVID-19testingto various federal and state public health authorities, including the Centers for Disease Control and Prevention, and participate in studies with government and private institutions,aidingCOVID-19public health response and research. Throughour team ofdedicatedphlebotomists, air fleet team, couriers andlaboratory professionals, Quest Diagnosticsworks hard every day to help patients and communities across the United States access qualityCOVID-19 testing.

The antibody tests and the molecular tests (together "All tests") have not been FDA cleared or approved; All tests have been authorized by FDA under EUAs for use by authorized laboratories; The antibody tests have been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens; The molecular tests have been authorized only for the detection of nucleic acid from SARSCoV-2, not for any other viruses or pathogens; and, All tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

For more information about the latest developments with our COVID-19 testing, visit: newsroom.questdiagnostics.com/COVIDTestingUpdates

https://c212.net/c/img/favicon.png?sn=NY79796&sd=2020-11-03

View original content to download multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-credit-suisse-29th-annual-virtual-healthcare-conference-301165935.html

SOURCE Quest Diagnostics

https://rt.prnewswire.com/rt.gif?NewsItemId=NY79796&Transmission_Id=202011031358PR_NEWS_USPR_____NY79796&DateId=20201103

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.